sungil im | Arrhythmia | Best Researcher Award

Posted on by Pencis

Dr. sungil im | Arrhythmia | Best Researcher Award

Dr. sungil im, kosin university, South Korea

Dr. Sungil Im is an Associate Professor of Cardiology at Kosin University Gospel Hospital, South Korea. With a distinguished career spanning over two decades, he specializes in cardiac electrophysiology, atrial myopathy, and advanced ablation techniques for arrhythmias. Dr. Im’s global expertise includes serving as an international cooperation doctor under KOICA in Kazakhstan and contributing to leading institutions like Korea University Medical Center and Samsung Medical Center. A Fellow of the American College of Cardiology (FACC) and European Society of Cardiology (FESC), his impactful research and clinical trials continue to shape advancements in cardiology worldwide.

Author Profile

Orcid Profile

Google Scholar Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Sungil Im’s journey in medicine began with a strong foundation in internal medicine and cardiology. After obtaining his Korean Medical Doctor license in 2003, he pursued a rigorous residency at Gyeong Sang National University Hospital, specializing in general internal medicine and cardiology. His academic milestones were marked by a continuous quest for excellence, which paved the way for his clinical expertise in cardiac electrophysiology.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Im’s professional journey is a testament to his dedication and versatility. From 2008 to 2011, he served as an international cooperation doctor under KOICA at the Korea-Kazakhstan Friendship Hospital. This experience underscored his global commitment to advancing healthcare. Upon returning to Korea, he held key positions such as Clinical Fellow and Assistant Professor at esteemed institutions, including the Korea University Medical Center and Samsung Medical Center. Currently, he is an Associate Professor at Kosin University Gospel Hospital, where he continues to contribute significantly to cardiology education and clinical practice.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ARRHYTHMIA:

Dr. Im’s research interests are deeply rooted in advanced cardiac electrophysiology. His groundbreaking studies focus on atrial myopathy, cryoablation techniques for atrial fibrillation, and ventricular tachycardia ablation. His investigations into arrhythmogenesis and inflammation in atrial fibrillation patients have opened new avenues for understanding cardiac diseases. Additionally, his work on the association between ventricular arrhythmias and stroke has provided critical insights into improving patient outcomes.

🌍 IMPACT AND INFLUENCE:

Dr. Im’s influence extends beyond academia and clinical practice. He is a Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC), reflecting his global recognition. As a board member of various Korean cardiology societies, he plays a vital role in shaping policies and advancing the field. His participation in multicenter clinical trials has further reinforced his reputation as a pioneer in cardiology research.

📖 ACADEMIC CITES:

Dr. Im has authored and contributed to numerous peer-reviewed studies and clinical trials, particularly in the fields of hypertension, medication adherence, and electrophysiology. His scholarly work is widely cited and respected, showcasing his intellectual contributions to cardiology.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Sungil Im’s legacy is one of relentless pursuit of excellence and innovation. His dedication to advancing cardiac care, mentoring future cardiologists, and driving groundbreaking research continues to leave a lasting impact. Looking ahead, his work promises to further enhance our understanding of complex cardiac disorders and improve global healthcare standards.

🌟 CONCLUSION:

Dr. Sungil Im exemplifies the qualities of a world-class researcher and educator. With a career marked by global service, pioneering research, and academic leadership, he stands as a beacon of inspiration in the field of cardiology. His legacy will undoubtedly influence generations to come.

TOP NOTABLE PUBLICATIONS

Pulsed field ablation of left ventricular myocardium in a swine infarct model

Authors: SI Im, S Higuchi, A Lee, C Stillson, E Buck, B Morrow, K Schneider, …

Journal: Clinical Electrophysiology

Year: 2022

Predictors of adverse outcome in patients with frequent premature ventricular complexes: the ABC-VT risk score

Authors: A Voskoboinik, A Hadjis, C Alhede, SI Im, H Park, J Moss, GM Marcus, …

Journal: Heart Rhythm

Year: 2020

Identification of markers associated with development of stroke in “Clinically Low‐Risk” atrial fibrillation patients

Authors: SY Shin, SJ Han, JS Kim, SI Im, J Shim, J Ahn, EM Lee, YM Park, JH Kim, …

Journal: Journal of the American Heart Association

Year: 2019

Effect of epicardial pulsed field ablation directly on coronary arteries

Authors: S Higuchi, SI Im, C Stillson, ED Buck, S Jerrell, CW Schneider, M Speltz, …

Journal: Clinical Electrophysiology

Year: 2022

Gap junction remodeling by chronic pressure overload is related to the increased susceptibility to atrial fibrillation in rat heart

Authors: SY Shin, WM Jo, TJ Min, BK Kim, DH Song, SH Hyeon, JE Kwon, WS Lee, …

Journal: EP Europace

Year: 2015

Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation

Authors: SI Im, SY Shin, JO Na, YH Kim, CU Choi, SH Kim, JW Kim, EJ Kim, …

Journal: International Journal of Cardiology

Year: 2013

Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients

Authors: JY Park, SW Rha, KL Poddar, S Ramasamy, KY Chen, YJ Li, BG Choi, …

Journal: Journal of Cardiology

Year: 2012

Thyrotoxicosis with coronary spasm that required coronary artery bypass surgery

Authors: SM Lee, TS Jung, JR Hahm, SI Im, SK Kim, KJ Lee, JM Lee, SI Chung

Journal: Internal Medicine

Year: 2007

Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy

Authors: KM Park, SI Im, SJ Park, JS Kim, YK On

Journal: International Journal of Cardiology

Year: 2017

Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation

Authors: SI Im, J Heo, BJ Kim, KI Cho, HS Kim, JH Heo, JY Hwang

Journal: Open Heart

Year: 2018

Songyun Wang | Arrhythmia | Best Researcher Award

Posted on by Pencis

Dr. Songyun Wang | Arrhythmia | Best Researcher Award

Ruoxi Zhang | Cardiology | Best Researcher Award

Posted on by Pencis

Dr. Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang, Harbin Medical University, China.

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.

Author Profile

Suitability for Best Researcher Award

Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.

Education:

Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.

Professional Experience:

Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.

Research Interests:

Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.

Recognition and Impact:

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.

Citations:

Citations – 576
h-index – 14
i10-index – 19

Conclusion:

Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.

 Top Notable Publications

Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway

Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …

Journal: Oxidative Medicine and Cellular Longevity

Year: 2020 📅

Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow

Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …

Journal: Journal of Translational Medicine

Year: 2019 📰

C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase

Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu

Journal: Journal of Cellular and Molecular Medicine

Year: 2017 🧬

C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways

Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou

Journal: Oncotarget

Year: 2017 💡

Identification of biomarkers for unstable angina by plasma metabolomic profiling

Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu

Journal: Molecular BioSystems

Year: 2013 🔬

Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction

Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …

Journal: Canadian Journal of Cardiology

Year: 2018 💓

Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention

Author(s): Q Zhao, R Zhang, J Hou, B Yu

Journal: Acta Cardiologica Sinica

Year: 2018 ❤️

C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway

Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …

Journal: Frontiers in Pharmacology

Year: 2021 💪

Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection

Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou

Journal: International Heart Journal

Year: 2016 ❤️

Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study

Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou

Journal: Scientific Reports

Year: 2016 🐇

Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis

Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu

Journal: Biomolecules & Therapeutics

Year: 2018 💉

Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …

Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou

Journal: Experimental and Therapeutic Medicine

Year: 2017 🏥

Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation

Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …

Journal: Clinical Science

Year: 2019 💉

Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study

Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu

Journal: BioMed Research International

Year: 2018 🧪

Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice

Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …

Journal: Journal of Molecular Endocrinology

Year: 2019 🐁

Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Posted on by Pencis

Prof. Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Dandan Tian | Hypertension | Best Researcher Award

Posted on by Pencis

Dr. Dandan Tian | Hypertension | Best Researcher Award

Dr.  Dandan Tian, Henan Provincial People’s Hospital, China

Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.

Author Profile

Scopus Profile

EARLY ACADEMIC PURSUITS:

Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.

PROFESSIONAL ENDEAVORS:

Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.

IMPACT AND INFLUENCE:

Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.

ACADEMIC CITES AND RECOGNITION:

Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.

CONCLUSION:

Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.

TOP NOTABLE PUBLICATIONS

Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank

Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.

Journal: IBRO Neuroscience Reports

Year: 2025

Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank

Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.

Journal: Stroke

Year: 2024

Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results

Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.

Journal: Frontiers in Endocrinology

Year: 2024

Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study

Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.

Journal: Frontiers in Cardiovascular Medicine

Year: 2024

Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2023

Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers

Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.

Journal: Pathology and Oncology Research

Year: 2021

Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS

Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.

Journal: Journal of Alloys and Compounds

Year: 2021

Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells

Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2021

Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors

Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.

Journal: Saudi Journal of Biological Sciences

Year: 2017

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present)  and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948

 

 

George Matsopoulos | Medical Imaging | Best Researcher Award

Posted on by Pencis

Prof. George Matsopoulos | Medical Imaging | Best Researcher Award

Mengchao Wei | Venous thromboembolism | Best Researcher Award

Posted on by Pencis

Dr. Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei, Peking Union Medical College Hospital, China

Dr. Mengchao Wei is a physician at Peking Union Medical College Hospital, China, specializing in Urology. He graduated with a Doctor’s degree from Sun Yat-sen University in 2019. Since joining PUMCH in 2021, Dr. Wei has focused on optimizing perioperative management for urologic surgeries. He developed a predictive model for venous thromboembolism risk post-surgery, now integrated into clinical practice. Dr. Wei has published 10 journal articles in SCI and Scopus indexed journals. His research aims to improve patient safety and surgical outcomes, making significant contributions to the field of urologic surgery.

Author Profile

Orcid Profile

📚Early Academic Pursuits: 

Dr. Mengchao Wei graduated with a Doctor’s degree from Sun Yat-sen University in 2019. His academic journey laid the foundation for his current work, particularly in the field of Urology, where he became deeply involved in understanding the nuances of perioperative management in urologic surgeries. His comprehensive training and early research set him on a path to clinical excellence and innovation.

⚕️Professional Endeavors and Contributions: 

Since 2021, Dr. Wei has been practicing as a Physician at Peking Union Medical College Hospital, where his focus lies in the optimization of perioperative management in urologic surgeries. His clinical work has had a direct impact on improving patient care and the efficiency of surgical outcomes. Dr. Wei’s contributions include the development of a predictive model for venous thromboembolism risk following urologic surgeries, which has been implemented in real-world clinical practice to enhance patient safety.

🔬Research Focus and Innovations on Venous thromboembolism:

Dr. Wei’s research centers on perioperative management within urology, particularly concerning venous thromboembolism (VTE) risk. His predictive model for VTE risk, now utilized in clinical settings, showcases his ability to translate research into tangible, life-saving outcomes. While his citation index stands at 10, his work continues to gain attention in the medical community. He has published 10 journals in esteemed databases such as SCI and Scopus, reinforcing his status as a respected figure in urologic research.

🌍Impact and Influence: 

Dr. Wei’s contributions have not only benefited his hospital but also shaped the way urologic surgeries are managed perioperatively. By providing a tool that enhances clinical decision-making, he directly improves surgical outcomes, patient safety, and overall healthcare efficiency. His work has influenced peers, setting a new standard in the field of urology.

📑Academic Citations:

Dr. Wei has an impressive citation index of 10, a reflection of the growing recognition of his work and the clinical value it brings. His research continues to receive acknowledgment in relevant medical journals, contributing to the advancement of perioperative care in urology.

🚀Legacy and Future Contributions: 

Dr. Wei’s research and innovations indicate a promising future in the field of urology. He is committed to enhancing perioperative management for urologic surgeries and advancing clinical practices. Moving forward, his aim is to refine predictive models and further contribute to patient safety and surgical excellence.

🌟Conclusion:

Dr. Mengchao Wei’s work at Peking Union Medical College Hospital has made a significant impact on perioperative management in urologic surgeries. His predictive model for venous thromboembolism risk has been successfully integrated into clinical practice, improving patient outcomes and safety. With 10 journal publications in SCI and Scopus indexed journals, Dr. Wei is recognized as a dedicated and innovative physician. His contributions are shaping the future of urologic surgery. As he continues to push the boundaries of medical research, his work promises to enhance the quality of care and patient safety worldwide.

Top Notable Publications 

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

Authors: Mengchao Wei

Journal: Scientific Reports

Year: 2025

The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma

Authors: Mengchao Wei

Journal: BMC Urology

Year: 2024

Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial

Authors: Mengchao Wei

Journal: World Journal of Urology

Year: 2024

Surgery or external beam radiation for solitary small hepatocellular carcinoma

Authors: Mengchao Wei

Journal: Journal of Cancer Research and Therapeutics

Year: 2023

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

Authors: Mengchao Wei

Journal: Frontiers in Oncology

Year: 2022

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2022

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer

Authors: Mengchao Wei

Journal: International Journal of Radiation Oncology, Biology, Physics

Year: 2022

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2020

Radiofrequency ablation plus nucleotide analogues for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis

Authors: Mengchao Wei

Journal: American Journal of Translational Research

Year: 2018

Sorafenib versus Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Authors: Mengchao Wei

Journal: BMC Cancer

Year: 2018

xie zhengxing | Cardiovascular Disease | Best Research Article Award

Posted on by Pencis

Prof. xie zhengxing | Cardiovascular Disease | Best Research Article Award 

Xiaodong Jiang | Critical Care Medicine | Best Researcher Award

Posted on by Pencis

Mr. Xiaodong Jiang | Critical Care Medicine | Best Researcher Award 

Mr. Xiaodong Jiang, Second Affiliated Hospital of Dalian Medical University, China

Mr. Xiaodong Jiang is a Chief Physician and Doctoral Researcher in Critical Care Medicine at the Second Affiliated Hospital of Dalian Medical University, China. As Deputy Director of the Critical Care Medicine Department, he excels in ECMO techniques and the management of severe and complex critical conditions. He is also a Master’s Supervisor, Party Branch Secretary, and Deputy Director of the Critical Care Medicine Teaching and Research Office. Actively involved in national and regional medical committees, he contributes to advancing critical care practices and education. His work in clinical innovation and academic leadership establishes him as a prominent expert in critical care medicine.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Mr. Jiang Xiaodong embarked on his academic journey with a clear focus on critical care medicine, quickly distinguishing himself as a dedicated scholar. His early studies laid the foundation for his expertise in managing life-threatening conditions, paving the way for his role as a Chief Physician and Doctoral Researcher. His academic excellence and commitment to learning were evident as he advanced through rigorous medical training and specialized in critical care medicine.

🩺PROFESSIONAL ENDEAVORS:

Mr. Jiang serves as the Deputy Director of the Critical Care Medicine Department and Deputy Director of the Critical Care Medicine Teaching and Research Office at the Second Affiliated Hospital of Dalian Medical University. In these roles, he combines clinical expertise with administrative responsibilities, ensuring the seamless functioning of critical care units and fostering innovation in patient care.

Additionally, as the Secretary of the Critical Care Medicine Party Branch, he demonstrates exemplary leadership, influencing policies and practices within the hospital’s critical care division.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CRITICAL CARE MEDICINE:

Mr. Jiang’s research focus includes groundbreaking work in ECMO (Extracorporeal Membrane Oxygenation) treatment techniques, such as VV-ECMO, VA-ECMO, and ECPR. His expertise has revolutionized the management of severe pneumonia, emergency PCI, and perioperative care for lung transplants.

His contributions extend to the development of advanced rescue strategies for critical conditions, solidifying his status as a leading innovator in critical care medicine. His research findings have practical applications, improving patient survival rates and recovery outcomes.

🌟IMPACT AND INFLUENCE 

Through his academic and professional positions, Mr. Jiang has significantly influenced critical care medicine at both regional and national levels. His active membership in various medical committees, including the Chinese Medical Doctor Association and Liaoning Medical Association, highlights his role in shaping critical care policies and advancing best practices.

His leadership extends to academic and clinical education, mentoring young professionals, and fostering the next generation of critical care specialists.

📝ACADEMIC CITES AND EDITORIAL CONTRIBUTIONS: 

Mr. Jiang is a recognized authority in his field, serving as an invited reviewer for prestigious journals, including the Chinese Journal of Emergency Medicine and the Chinese Journal of Critical Care Medicine.

As an Editorial Board Member of the Chinese Journal of Postgraduate Medical Education, he ensures the dissemination of high-impact research, further enhancing the academic landscape of critical care medicine.

🌍LEGACY AND FUTURE CONTRIBUTIONS: 

Mr. Jiang’s legacy is defined by his unwavering commitment to advancing critical care medicine. His work in ECMO techniques, patient-centered care, and innovative research sets a benchmark for excellence.

Looking to the future, Mr. Jiang is poised to continue his groundbreaking research and expand his influence, leaving an indelible mark on critical care medicine. His dedication inspires colleagues and students alike, ensuring that his contributions will resonate for years to come.

🏆FINAL REMARKS AND RECOGNITION:

Mr. Jiang Xiaodong embodies the qualities of a distinguished researcher, clinician, and academic leader. His comprehensive achievements in critical care medicine make him a deserving candidate for any accolade recognizing excellence and innovation in medical science. Recognizing his contributions will not only honor his work but also inspire continued progress in the field of critical care medicine.

🌟CONCLUSION:

Mr. Xiaodong Jiang stands as a beacon of excellence in critical care medicine, seamlessly blending clinical expertise, academic leadership, and innovative research. His groundbreaking work in ECMO techniques and dedication to improving patient outcomes have set new standards in the field. Through his roles in education and professional organizations, he continues to inspire the next generation of medical professionals.

With his unwavering commitment to advancing critical care practices, Mr. Jiang’s contributions will leave a lasting impact on the medical community. He is a true leader and innovator, deserving of recognition and admiration.

TOP NOTABLE PUBLICATIONS:

Machine learning for predicting acute myocardial infarction in patients with sepsis

Authors: Fang, S., Jin, H., Zhang, J., Su, W., Jiang, X.

Journal: Scientific Reports

Year: 2024

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

Authors: Gong, D., Yu, J., Jiang, X.

Journal: Frontiers in Oncology

Year: 2022

Effect of MIR-26a targeting GSK-3β/β-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion

Authors: Gong, D.-D., Yu, J., Yu, J.-C., Jiang, X.-D.

Journal: European Review for Medical and Pharmacological Sciences

Year: 2019

Takotsubo-like cardiomyopathy in a giant pheochromocytoma

Authors: Zhu, D., Yu, J., Li, X., Jiang, X., Zhuang, C.

Journal: International Journal of Cardiology

Year: 2014